Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA.

J Am Soc Nephrol. 2019 Jan 8. pii: ASN.2018080815. doi: 10.1681/ASN.2018080815. [Epub ahead of print]

PMID:
30622155
2.

Use of delayed intervention for small renal masses initially managed with active surveillance.

Gupta M, Alam R, Patel HD, Semerjian A, Gorin MA, Johnson MH, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

Urol Oncol. 2019 Jan;37(1):18-25. doi: 10.1016/j.urolonc.2018.10.001. Epub 2018 Nov 13.

PMID:
30446459
3.

Patient Decision-making and Predictors of Genital Satisfaction Associated With Testicular Prostheses After Radical Orchiectomy: A Questionnaire-based Study of Men With Germ Cell Tumors of the Testicle.

Nichols PE, Harris KT, Brant A, Manka MG, Haney N, Johnson MH, Herati A, Allaf ME, Pierorazio PM.

Urology. 2018 Oct 28. pii: S0090-4295(18)31053-7. doi: 10.1016/j.urology.2018.09.021. [Epub ahead of print]

PMID:
30381246
4.

Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy.

Patel HD, Karam JA, Allaf ME.

J Clin Oncol. 2018 Oct 29:JCO2018790246. doi: 10.1200/JCO.2018.79.0246. [Epub ahead of print]

PMID:
30372387
5.

Consumers' Association of Hospital Reputation With Healthcare Quality.

Ziemba JB, Arenberg S, Reustle H, Allaf ME, Haldeman D.

J Healthc Qual. 2018 Oct 24. doi: 10.1097/JHQ.0000000000000167. [Epub ahead of print]

PMID:
30358634
6.

A Prospective Cohort Study of Postdischarge Opioid Practices After Radical Prostatectomy: The ORIOLES Initiative.

Patel HD, Srivastava A, Patel ND, Faisal FA, Ludwig W, Joice GA, Schwen ZR, Allaf ME, Han M, Herati AS.

Eur Urol. 2019 Feb;75(2):215-218. doi: 10.1016/j.eururo.2018.10.013. Epub 2018 Oct 21.

PMID:
30352714
7.

Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT.

Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA.

Mol Imaging Biol. 2018 Sep 14. doi: 10.1007/s11307-018-1271-2. [Epub ahead of print]

PMID:
30218388
8.

Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer.

Meyer AR, Joice GA, Allaf ME, Rowe SP, Gorin MA.

Curr Opin Urol. 2018 Nov;28(6):493-498. doi: 10.1097/MOU.0000000000000549.

PMID:
30188333
9.

Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy.

Srivastava A, Meyer AR, Pierorazio PM, Rowe SP, Allaf ME, Gorin MA.

Clin Genitourin Cancer. 2018 Dec;16(6):e1083-e1085. doi: 10.1016/j.clgc.2018.07.012. Epub 2018 Jul 21. No abstract available.

PMID:
30097254
10.

Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.

Alam R, Patel HD, Osumah T, Srivastava A, Gorin MA, Johnson MH, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

BJU Int. 2019 Jan;123(1):42-50. doi: 10.1111/bju.14490. Epub 2018 Aug 9.

PMID:
30019484
11.

Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- "intermediate mononuclear phagocytic cells".

Lee SA, Noel S, Sadasivam M, Allaf ME, Pierorazio PM, Hamad ARA, Rabb H.

PLoS One. 2018 Jun 1;13(6):e0198608. doi: 10.1371/journal.pone.0198608. eCollection 2018. Erratum in: PLoS One. 2018 Jun 27;13(6):e0200056.

12.

Intraoperative Nerve Monitoring in Robotic-Assisted Resection Of Presacral Ganglioneuroma: Operative Technique.

Garzon-Muvdi T, Belzberg A, Allaf ME, Wolinsky JP.

Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):103-110. doi: 10.1093/ons/opy040.

PMID:
29554323
13.

Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms.

Salas Fragomeni RA, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, Kiess AP, Allaf ME, Pomper MG, Gorin MA, Rowe SP.

J Nucl Med. 2018 Jun;59(6):871-877. doi: 10.2967/jnumed.117.203570. Epub 2018 Mar 15.

PMID:
29545375
14.

Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation.

Shenderov E, Gorin MA, Kim S, Johnson PT, Allaf ME, Partin AW, Pomper MG, Antonarakis ES, Pienta KJ, Rowe SP.

Urol Case Rep. 2017 Dec 19;17:22-25. doi: 10.1016/j.eucr.2017.12.011. eCollection 2018 Mar.

15.

Re: Almassi et al.: Use of 99mTc-Sestamibi Single-photon Emission Computed Tomography / X-ray Computed Tomography in the Diagnosis of Hybrid Oncocytic / Chromophobe Tumor in a Pediatric Patient. (Urology 2018;113:206-208).

Campbell SC, McKenney JK, Almassi N, Gorin MA, Rowe SP, Purysko AS, Kaouk J, Allaf ME, Rhee A.

Urology. 2018 Jun;116:234-235. doi: 10.1016/j.urology.2018.01.050. Epub 2018 Mar 9. No abstract available.

PMID:
29530542
16.

Photorealistic 3-Dimensional Cinematic Rendering of Clear Cell Renal Cell Carcinoma From Volumetric Computed Tomography Data.

Rowe SP, Gorin MA, Allaf ME, Johnson PT, Fishman EK.

Urology. 2018 May;115:e3-e5. doi: 10.1016/j.urology.2018.02.011. Epub 2018 Feb 27.

PMID:
29499261
17.

Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.

Meyer AR, Joice GA, Schwen ZR, Partin AW, Allaf ME, Gorin MA.

Urology. 2018 May;115:8-13. doi: 10.1016/j.urology.2018.01.021. Epub 2018 Feb 1.

PMID:
29409845
18.

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial.

Patel HD, Allaf ME.

Eur Urol Focus. 2018 Jan 17. pii: S2405-4569(18)30003-8. doi: 10.1016/j.euf.2018.01.002. [Epub ahead of print]

PMID:
29373284
19.

The role of molecular imaging in the characterization of renal masses.

Meyer AR, Allaf ME, Rowe SP, Gorin MA.

Curr Opin Urol. 2018 Mar;28(2):159-165. doi: 10.1097/MOU.0000000000000479.

PMID:
29319547
20.

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.

Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, Norton C, Bossé D, Wankowicz SM, Cullen D, Horak C, Wind-Rotolo M, Tracy A, Giannakis M, Hodi FS, Drake CG, Ball MW, Allaf ME, Snyder A, Hellmann MD, Ho T, Motzer RJ, Signoretti S, Kaelin WG Jr, Choueiri TK, Van Allen EM.

Science. 2018 Feb 16;359(6377):801-806. doi: 10.1126/science.aan5951. Epub 2018 Jan 4.

21.

99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

Campbell SP, Tzortzakakis A, Javadi MS, Karlsson M, Solnes LB, Axelsson R, Allaf ME, Gorin MA, Rowe SP.

Br J Radiol. 2018 Apr;91(1084):20170526. doi: 10.1259/bjr.20170526. Epub 2018 Feb 27. Review.

PMID:
29271233
22.

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.

Ross AE, Hughes RM, Glavaris S, Ghabili K, He P, Anders NM, Harb R, Tosoian JJ, Marchionni L, Schaeffer EM, Partin AW, Allaf ME, Bivalacqua TJ, Chapman C, O'Neal T, DeMarzo AM, Hurley PJ, Rudek MA, Antonarakis ES.

Oncotarget. 2017 Oct 26;8(61):104182-104192. doi: 10.18632/oncotarget.22115. eCollection 2017 Nov 28.

23.

Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses.

Jones KM, Solnes LB, Rowe SP, Gorin MA, Sheikhbahaei S, Fung G, Frey EC, Allaf ME, Du Y, Javadi MS.

Ann Nucl Med. 2018 Feb;32(2):87-93. doi: 10.1007/s12149-017-1222-z. Epub 2017 Dec 6.

PMID:
29214562
24.

Margin Assessment in Renal Surgery Using a Handheld Optical Coherence Tomography Probe.

Ludwig WW, Wobker SE, Ball MW, Zysk AM, Yemul KS, Pierorazio PM, Gorin MA, Allaf ME.

Urology. 2018 Mar;113:241-245. doi: 10.1016/j.urology.2017.11.029. Epub 2017 Nov 28.

PMID:
29196067
25.

Use of 99mTc-sestamibi Single-photon Emission Computed Tomography / X-ray Computed Tomography in the Diagnosis of Hybrid Oncocytic / Chromophobe Tumor in a Pediatric Patient.

Almassi N, Gorin MA, Purysko AS, Rowe SP, Kaouk J, Allaf ME, Campbell SC, Rhee A.

Urology. 2018 Mar;113:206-208. doi: 10.1016/j.urology.2017.11.015. Epub 2017 Nov 23.

PMID:
29174943
26.

Selecting Patients with Small Renal Masses for Active Surveillance.

Johnson MH, Allaf ME, Pierorazio PM.

Anticancer Agents Med Chem. 2018;18(7):931-939. doi: 10.2174/1871520617666171113152225.

PMID:
29141556
27.

Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma.

Campbell SP, Baras AS, Ball MW, Kates M, Hahn NM, Bivalacqua TJ, Johnson MH, Pomper MG, Allaf ME, Rowe SP, Gorin MA.

Ann Nucl Med. 2018 Jan;32(1):69-74. doi: 10.1007/s12149-017-1216-x. Epub 2017 Oct 24.

28.

Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.

Patel HD, Joice GA, Schwen ZR, Semerjian A, Alam R, Srivastava A, Allaf ME, Pierorazio PM.

World J Urol. 2018 Jan;36(1):73-78. doi: 10.1007/s00345-017-2099-0. Epub 2017 Oct 12.

PMID:
29026972
29.

Multiple growth periods predict unfavourable pathology in patients with small renal masses.

Jang A, Patel HD, Riffon M, Gorin MA, Semerjian A, Johnson MH, Allaf ME, Pierorazio PM.

BJU Int. 2018 May;121(5):732-736. doi: 10.1111/bju.14051. Epub 2017 Nov 1.

PMID:
28990323
30.

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

Rowe SP, Gorin MA, Solnes LB, Ball MW, Choudhary A, Pierorazio PM, Epstein JI, Javadi MS, Allaf ME, Baras AS.

EJNMMI Res. 2017 Oct 2;7(1):80. doi: 10.1186/s13550-017-0329-5.

31.

Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.

Srivastava A, Patel HD, Joice GA, Semerjian A, Gorin MA, Johnson MH, Allaf ME, Pierorazio PM.

Urol Oncol. 2018 Jan;36(1):12.e7-12.e13. doi: 10.1016/j.urolonc.2017.09.005. Epub 2017 Sep 29.

PMID:
28970053
32.

Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.

Uzosike AC, Patel HD, Alam R, Schwen ZR, Gupta M, Gorin MA, Johnson MH, Gausepohl H, Riffon MF, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

J Urol. 2018 Mar;199(3):641-648. doi: 10.1016/j.juro.2017.09.087. Epub 2017 Sep 23.

PMID:
28951284
33.

Frontiers in robot-assisted retroperitoneal oncological surgery.

Ludwig WW, Gorin MA, Pierorazio PM, Allaf ME.

Nat Rev Urol. 2017 Dec;14(12):731-741. doi: 10.1038/nrurol.2017.149. Epub 2017 Sep 12. Review.

PMID:
28895564
34.

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.

Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP.

Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.

35.

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, Pienta KJ, Allaf ME, Haberkorn U, Pomper MG, Gorin MA, Rowe SP.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2117-2136. doi: 10.1007/s00259-017-3780-7. Epub 2017 Aug 1. Review.

PMID:
28765998
36.

The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.

Ball MW, Gorin MA, Drake CG, Hammers HJ, Allaf ME.

Eur Urol Focus. 2017 Dec;3(6):584-589. doi: 10.1016/j.euf.2017.01.007. Epub 2017 Feb 8.

37.

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME.

J Urol. 2018 Jan;199(1):126-132. doi: 10.1016/j.juro.2017.07.070. Epub 2017 Jul 20.

38.

Safety and Feasibility of Direct Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Using a Novel Magnetic Resonance Imaging-safe Robotic Device.

Ball MW, Ross AE, Ghabili K, Kim C, Jun C, Petrisor D, Pan L, Epstein JI, Macura KJ, Stoianovici DS, Allaf ME.

Urology. 2017 Nov;109:216-221. doi: 10.1016/j.urology.2017.07.010. Epub 2017 Jul 19.

PMID:
28735018
39.

Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival.

Patel HD, Srivastava A, Alam R, Joice GA, Schwen ZR, Semerjian A, Allaf ME, Pierorazio PM.

Urol Oncol. 2017 Oct;35(10):606.e1-606.e7. doi: 10.1016/j.urolonc.2017.06.051. Epub 2017 Jul 13.

PMID:
28712791
40.

Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.

Gorin MA, Marashdeh W, Ross AE, Allaf ME, Pienta KJ, Pomper MG, Rowe SP.

Nucl Med Commun. 2017 Sep;38(9):795-798. doi: 10.1097/MNM.0000000000000716.

PMID:
28704341
41.

Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Patel HD, Pierorazio PM, Johnson MH, Sharma R, Iyoha E, Allaf ME, Bass EB, Sozio SM.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1057-1069. doi: 10.2215/CJN.11941116. Epub 2017 May 8. Review.

42.

Renal Mass and Localized Renal Cancer: AUA Guideline.

Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM.

J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.

PMID:
28479239
43.

Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?

Rowe SP, Javadi MS, Allaf ME, Gorin MA.

EJNMMI Res. 2017 Dec;7(1):34. doi: 10.1186/s13550-017-0277-0. Epub 2017 Apr 12. No abstract available.

44.

Defining the Role of Intraoperative Transesophageal Echocardiography During Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Kostibas MP, Arora V, Gorin MA, Ball MW, Pierorazio PM, Allaf ME, Nyhan D, Brady MB.

Urology. 2017 Sep;107:161-165. doi: 10.1016/j.urology.2017.03.008. Epub 2017 Mar 30.

PMID:
28366705
45.

Active surveillance is superior to radical nephrectomy and equivalent to partial nephrectomy for preserving renal function in patients with small renal masses: Results from the DISSRM registry.

Danzig MR, Ghandour RA, Chang P, Wagner AA, Pierorazio PM, Allaf ME, McKiernan JM.

Urol Oncol. 2017 Mar;35(3):116. doi: 10.1016/j.urolonc.2016.05.011.

PMID:
28215846
46.

Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma.

Falegan OS, Ball MW, Shaykhutdinov RA, Pieroraio PM, Farshidfar F, Vogel HJ, Allaf ME, Hyndman ME.

Metabolites. 2017 Feb 3;7(1). pii: E6. doi: 10.3390/metabo7010006.

47.

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS.

Clin Nucl Med. 2017 Apr;42(4):e188-e193. doi: 10.1097/RLU.0000000000001534.

PMID:
28114223
48.

Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis.

Patel HD, Gorin MA, Gupta N, Kates M, Johnson MH, Pierorazio PM, Allaf ME.

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):389-395. doi: 10.5489/cuaj.1999.

49.

Renal Pseudoaneurysm Mimicking Local Cancer Recurrence After Partial Nephrectomy.

Campbell SP, Rowe SP, Gorin MA, Allaf ME.

Urol Case Rep. 2016 Dec 30;11:1-3. doi: 10.1016/j.eucr.2016.10.011. eCollection 2017 Feb.

50.

Evaluation of a Large Renal Mass Using 99mTc-MIBI SPECT/CT in a Patient With Chronic Kidney Disease.

Rowe SP, Gorin MA, Javadi MS, Allaf ME.

Clin Nucl Med. 2017 Mar;42(3):e166-e167. doi: 10.1097/RLU.0000000000001533.

PMID:
28072625

Supplemental Content

Loading ...
Support Center